Commodities, Exporters and Properties Emerge as China Stocks Winners

Gene Linn |

China stocksBoom went the dynamite. China stocks shot higher Friday after the U.S. Federal Reserve launched an eagerly anticipated round of monetary easing, the so-called QE3. Chinese commodity producers, exporters and properties will continue to rise sharply in the coming months, according to one analyst.

Hong Kong’s Hang Seng Index surged 2.9% to 20,630 in greatly expanded turnover after the Fed announced it would add massive amounts of money to the U.S. economy through bond purchases. The index of Chinese companies jumped 3.7%. Big gains Friday allowed both indexes to rise 4.2% for the week. Easier European policies are also boosting the market. Last Friday the Hang Seng leaped 3.1% on news of an ECB bond-buying plan.

“It’s not just QE3 that helped the market,” said Peter So, managing director and co-head of research at CCB International. “The Fed also raised its GDP growth forecasts for 2013 and 2014, which shows the economy has more momentum.”

CCB International is the brokerage arm of China Construction Bank, one of China’s “big four” banks.
The boost to the U.S. economy creates three themes for China stocks, he said.

One is for commodity producers as the flood of new money pushes commodity prices higher. So likes gold stocks such as Zhaojin Mining (ZHAOY).

Exporters will also gain. “Exports from emerging markets are low now, but will expand next year,” according to So. Electronic components maker AAC Technologies (AACAY), TV producer TCL Multimedia (1070, HK) and Johnson Electric (JELCY) are among his favorites. Port operators such as China Merchants Holding (CMHHY) will also shine.

The third theme involves properties. So reasoned that QE3 will lead to a rise in currently low inflation rates, which will push investors into assets like properties. In addition the Hong Kong companies, he likes Chinese property giant Shimao (SHMAY). End

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BCDA BioCardia Inc 0.34 0.04 13.97 980,768

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…